{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:40:47Z","timestamp":1786984847292,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000883","name":"University of Bristol","doi-asserted-by":"publisher","award":["MC_UU_00011\/1"],"award-info":[{"award-number":["MC_UU_00011\/1"]}],"id":[{"id":"10.13039\/501100000883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["9039-00360B"],"award-info":[{"award-number":["9039-00360B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008208","name":"Overl\u00e6ge Johan Boserup og Lise Boserups Legat","doi-asserted-by":"publisher","award":["20795\u201324"],"award-info":[{"award-number":["20795\u201324"]}],"id":[{"id":"10.13039\/501100008208","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.atherosclerosis.2023.117316","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T12:03:13Z","timestamp":1695816193000},"page":"117316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Triglyceride content increases while cholesterol content decreases in HDL and LDL+IDL fractions following normal meals: The Copenhagen General Population Study of 25,656 individuals"],"prefix":"10.1016","volume":"383","author":[{"given":"Mia \u00d8.","family":"Johansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Moreno-Vedia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mie","family":"Balling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Davey Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rge G.","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.atherosclerosis.2023.117316_bib1","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.jacc.2017.08.006","article-title":"A test in context: lipid profile, fasting versus nonfasting","volume":"70","author":"Nordestgaard","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"20","key":"10.1016\/j.atherosclerosis.2023.117316_bib2","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.108.804146","article-title":"Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction","volume":"118","author":"Langsted","year":"2008","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2023.117316_bib3","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/archinternmed.2012.3708","article-title":"Fasting time and lipid levels in a community-based population: a cross-sectional study","volume":"172","author":"Sidhu","year":"2012","journal-title":"Arch. Intern. Med."},{"issue":"25","key":"10.1016\/j.atherosclerosis.2023.117316_bib4","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/eurheartj\/ehw152","volume":"37","author":"Nordestgaard","year":"2016","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117316_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women","volume":"298","author":"Bansal","year":"2007","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117316_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2023.117316_bib7","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/CIRCULATIONAHA.108.777334","article-title":"Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events","volume":"118","author":"Mora","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117316_bib8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2019","journal-title":"Eur. Heart J."},{"issue":"25","key":"10.1016\/j.atherosclerosis.2023.117316_bib9","first-page":"e1082","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2018","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2023.117316_bib10","first-page":"1129","article-title":"Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can. J. Cardiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117316_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/157016111795495530","article-title":"Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis","volume":"9","author":"Mihas","year":"2011","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2023.117316_bib12","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0002-9149(01)02047-1","article-title":"Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease","volume":"88","author":"Schaefer","year":"2001","journal-title":"Am. J. Cardiol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2023.117316_bib13","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/clinchem\/34.12.2456","article-title":"Lipoprotein cholesterol concentrations in the plasma of human subjects as measured in the fed and fasted states","volume":"34","author":"Cohn","year":"1988","journal-title":"Clin. Chem."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2023.117316_bib14","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0026-0495(03)00315-9","article-title":"Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size","volume":"52","author":"Blackburn","year":"2003","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2023.117316_bib15","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/0026-0495(95)90108-6","article-title":"Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease","volume":"44","author":"Hughes","year":"1995","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.117316_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1161\/01.ATV.13.4.521","article-title":"Increased postprandial lipemia in Apo A-IMilano carriers","volume":"13","author":"Calabresi","year":"1993","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2023.117316_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1476-511X-10-181","article-title":"High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study","volume":"10","author":"Wojczynski","year":"2011","journal-title":"Lipids Health Dis."},{"issue":"32","key":"10.1016\/j.atherosclerosis.2023.117316_bib18","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117316_bib19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jacc.2022.10.019","article-title":"Elevated LDL triglycerides and atherosclerotic risk","volume":"81","author":"Balling","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.117316_bib20","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz265","article-title":"Low high-density lipoprotein cholesterol to monitor long-term average increased triglycerides","volume":"105","author":"Langsted","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2023.117316_bib21","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/aje\/kwx016","article-title":"Quantitative serum nuclear magnetic resonance metabolomics in large-scale Epidemiology: a primer on -omic technologies","volume":"186","author":"Wurtz","year":"2017","journal-title":"Am. J. Epidemiol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2023.117316_bib22","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1039\/b910205a","article-title":"High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism","volume":"134","author":"Soininen","year":"2009","journal-title":"Analyst"},{"key":"10.1016\/j.atherosclerosis.2023.117316_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.atherosclerosis.2020.03.028","article-title":"Reply to: \"Methodological issues regarding: \"A third of nonfasting plasma cholesterol is in remnant lipoproteins: lipoprotein subclass profiling in 9293 individuals\"\"","volume":"302","author":"Wurtz","year":"2020","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117316_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0021-9150(88)90060-3","article-title":"Hyperglycemia in normotriglyceridemic, hypercholesterolemic insulin-treated diabetic rabbits does not accelerate atherogenesis","volume":"72","author":"Nordestgaard","year":"1988","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2023.117316_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2019.05.011","article-title":"A third of nonfasting plasma cholesterol is in remnant lipoproteins: lipoprotein subclass profiling in 9293 individuals","volume":"286","author":"Balling","year":"2019","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.117316_bib26","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1161\/ATVBAHA.120.315639","article-title":"Per-particle triglyceride-rich lipoproteins imply higher myocardial infarction risk than low-density lipoproteins: Copenhagen general population study","volume":"41","author":"Johansen","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"23","key":"10.1016\/j.atherosclerosis.2023.117316_bib27","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1016\/j.jacc.2020.09.610","article-title":"VLDL cholesterol accounts for one-half of the risk of myocardial infarction associated with apoB-containing lipoproteins","volume":"76","author":"Balling","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.117316_bib28","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73951","article-title":"Constructing an atlas of associations between polygenic scores from across the human phenome and circulating metabolic biomarkers","volume":"11","author":"Fang","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.atherosclerosis.2023.117316_bib29","article-title":"High-density lipoprotein revisited: biological functions and clinical relevance","author":"von Eckardstein","year":"2022","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2023.117316_bib30","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1194\/jlr.R082735","article-title":"Cholesteryl ester transfer protein and its inhibitors","volume":"59","author":"Shrestha","year":"2018","journal-title":"J. Lipid Res."},{"issue":"17","key":"10.1016\/j.atherosclerosis.2023.117316_bib31","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.jacc.2020.02.059","article-title":"Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease","volume":"75","author":"Duran","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"20","key":"10.1016\/j.atherosclerosis.2023.117316_bib32","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.117316_bib33","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1172\/JCI111624","article-title":"Postprandial lipemia. A key for the conversion of high density lipoprotein 2 into high density lipoprotein 3 by hepatic lipase","volume":"74","author":"Patsch","year":"1984","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117316_bib34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/ajcn\/60.3.374","article-title":"Effects of moderate amounts of emulsified dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults","volume":"60","author":"Dubois","year":"1994","journal-title":"Am. J. Clin. Nutr."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2023.117316_bib35","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0895-4356(91)90155-3","article-title":"How independent are \"independent\" effects? Relative risk estimation when correlated exposures are measured imprecisely","volume":"44","author":"Phillips","year":"1991","journal-title":"J. Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117316_bib36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ije\/dyaa016","article-title":"Correlation without a cause: an epidemiological odyssey","volume":"49","author":"Davey Smith","year":"2020","journal-title":"Int. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117316_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0009-8981(98)00073-4","article-title":"Measurement of postprandial remnant-like particles (RLPs) following a fat-loading test","volume":"275","author":"Tanaka","year":"1998","journal-title":"Clin. Chim. Acta"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2023.117316_bib38","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/S0022-2275(20)35345-1","article-title":"Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters","volume":"34","author":"Cohn","year":"1993","journal-title":"J. Lipid Res."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2023.117316_bib39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41569-022-00676-y","article-title":"Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia","volume":"19","author":"Boren","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"issue":"15\u201316","key":"10.1016\/j.atherosclerosis.2023.117316_bib40","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.cca.2011.04.018","article-title":"Postprandial lipoprotein metabolism: VLDL vs chylomicrons","volume":"412","author":"Nakajima","year":"2011","journal-title":"Clin. Chim. Acta"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023052371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023052371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:28:01Z","timestamp":1762187281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915023052371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":40,"alternative-id":["S0021915023052371"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117316","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triglyceride content increases while cholesterol content decreases in HDL and LDL+IDL fractions following normal meals: The Copenhagen General Population Study of 25,656 individuals","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117316"}}